During the last 15-20 years, researchers at the Department of Urology have systematically collected tissue samples and clinical data from patients with treated for bladder and prostate cancer. This has led to establishment of an important biobank in collaboration with the Department of Molecular Medicine (MOMA); the biobank and has for a decade been an important source of internationally recognized cancer research.
In prostate cancer the department is also involved in research in epidemiology, screening tools, lifestyle interventions as well as medical intervention studies. The molecular signatures of bladder and prostate cancers have also received special attention. Several important tissue micro arrays (TMA) have been developed in collaboration with the Department of Histopathology.
- Molecular prediction of prostate cancer risk and aggressiveness
- Individual Prostate Cancer
- The molecular signature of clinical localised prostate cancer
- Tissue Engineering – Robotics in urology
- Identification of surgical stress and recovery in open and robot-assisted cystectomy in bladder cancer
- Urogenital reconstructive surgery of congenital malformations; an animal model
- The beneficial effect of substances in rye on prostate cancer (RyeproC)